Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.61 |
| ▸ | POLB | P06746 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.53 |
| ▸ | MAPK13 | O15264 | 3/20 | 0.53 |
| ▸ | MAPK12 | P53778 | 3/20 | 0.53 |
| ▸ | MAPK11 | Q15759 | 3/20 | 0.53 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.53 |
| ▸ | RAF1 | P04049 | 2/20 | 0.53 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.53 |
| ▸ | GCGR | P47871 | 1/20 | 0.51 |
| ▸ | NT5E | P21589 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | HPGD | P15428 | 3/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18843373 | 0.85 | MAPT (0.57) | KDM4EKMT2AMEN1MAPK13MAPK12 | |
| SCHEMBL18750608 | 0.85 | MGAM (0.61) | MGAMKDM4EPOLBKMT2AMEN1 | |
| SCHEMBL17133348 | 0.84 | MGAM (0.77) | MGAMKDM4EPOLBKMT2AMEN1 | |
| SCHEMBL8486213 | 0.83 | MAPK14 (0.72) | KDM4EMAPK13MAPK12MAPK11MAPK14 | |
| SCHEMBL15547027 | 0.82 | MGAM (0.75) | MGAMKDM4EPOLBKMT2AMEN1 | |
| SCHEMBL18840149 | 0.81 | MAPT (0.53) | KDM4EKMT2AMEN1MAPK13MAPK12 | |
| SCHEMBL29668054 | 0.80 | MGAM (0.73) | MGAMKDM4EPOLBKMT2AMEN1 | |
| SCHEMBL7087374 | 0.80 | ALOX5 (0.62) | MAPK11MAPK14ALDH1A1 | |
| SCHEMBL18843398 | 0.79 | NOX1 (0.57) | MGAMKDM4EPOLBKMT2AMEN1 | |
| SCHEMBL739928 | 0.78 | MAPK13 (0.72) | MGAMKDM4EPOLBKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115181068-B | TPI derivative fluorescent probe and application thereof in preparation of copper ion detection reagent | 南京师范大学 | 2023-10-27 | — | — | CN | disclosed |
| CN-115181068-A | TPI derivative fluorescent probe and application thereof in preparation of copper ion detection reagent | 南京师范大学 | 2022-10-14 | — | — | CN | disclosed |
| US-9834723-B2 | Pentaarylbiimidazole compound and production method for said compound | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2017-12-05 | — | — | US | disclosed |
| US-9834723-B2 | Pentaarylbiimidazole compound and production method for said compound | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2017-12-05 | — | — | US | disclosed |
| US-9834723-B2 | Pentaarylbiimidazole compound and production method for said compound | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2017-12-05 | — | — | US | disclosed |
| US-20170130124-A1 | PENTAARYLBIIMIDAZOLE COMPOUND AND PRODUCTION METHOD FOR SAID COMPOUND | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2017-05-11 | — | — | US | disclosed |
| US-20170130124-A1 | PENTAARYLBIIMIDAZOLE COMPOUND AND PRODUCTION METHOD FOR SAID COMPOUND | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2017-05-11 | — | — | US | disclosed |
| US-20170130124-A1 | PENTAARYLBIIMIDAZOLE COMPOUND AND PRODUCTION METHOD FOR SAID COMPOUND | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2017-05-11 | — | — | US | disclosed |
| WO-2015147126-A1 | PENTAARYLBIIMIDAZOLE COMPOUND AND PRODUCTION METHOD FOR SAID COMPOUND | 関東化学株式会社 | 2015-10-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170130124-A1 | PENTAARYLBIIMIDAZOLE COMPOUND AND PRODUCTION METHOD FOR SAID COMPOUND | PPOX, CDK4, PAICS | MGAM 1966/4885KDM4E 1198/4885POLB 641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.